Continue Reading
Full article on Yahoo Finance
GRI Bio Announces Reverse Stock Split
Market Intelligence Analysis
AI-Powered 80% GROQ-LLAMA-3.1-8B-INSTANT
Why This Matters
GRI Bio, a biotechnology company, announced a 1-for-28 reverse stock split, effective January 26, 2026, aiming to increase the company's stock price and potentially improve its market presence.
Market Impact
Market impact analysis based on bullish sentiment with 80% confidence.
Sentiment
Bullish
AI Confidence
80%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
GRI’s common stock is expected to begin trading on a post-split adjusted basis on January 26, 2026 LA JOLLA, CA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of immune cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that the board of directors of the Company approved a 1-for-28 reverse stock split (the “Reverse Split”) of the Company’s commo
AI Breakdown
Summary
GRI Bio, a biotechnology company, announced a 1-for-28 reverse stock split, effective January 26, 2026, aiming to increase the company's stock price and potentially improve its market presence.
Market Impact
Market impact analysis based on bullish sentiment with 80% confidence.
Time Horizon
Short Term
Original article published by
Yahoo Finance
on January 22, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.